| Original language | English |
|---|---|
| Pages (from-to) | 5-7 |
| Number of pages | 3 |
| Journal | Int. J. Biol. Markers |
| Volume | 35 |
| Issue number | 1_suppl |
| DOIs | |
| Publication status | Published - 2019 |
Keywords
- biological marker
- circulating microRNA
- tumor marker
- Article
- cancer diagnosis
- cancer prognosis
- clinical practice
- computer assisted tomography
- genomics
- human
- hypoxia
- inflammation
- inflammatory disease
- malignant neoplasm
- metabolomics
- metastasis
- molecular imaging
- nuclear magnetic resonance imaging
- oncology
- personalized medicine
- positron emission tomography-computed tomography
- single photon emission computed tomography
- tumor growth
- tumor microenvironment
- blood
- metabolism
- procedures
- Biomarkers
- Humans
- Inflammation
- Medical Oncology
- Molecular Imaging
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
The role of molecular and imaging biomarkers in the evaluation of inflammation in oncology : International Journal of Biological Markers. / Canese, R.; Bazzocchi, A.; Blandino, G.; Carpinelli, G.; De Nuccio, C.; Gion, M.; Moretti, F.; Soricelli, A.; Spessotto, P.; Iorio, E.
In: Int. J. Biol. Markers, Vol. 35, No. 1_suppl, 2019, p. 5-7.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The role of molecular and imaging biomarkers in the evaluation of inflammation in oncology
T2 - International Journal of Biological Markers
AU - Canese, R.
AU - Bazzocchi, A.
AU - Blandino, G.
AU - Carpinelli, G.
AU - De Nuccio, C.
AU - Gion, M.
AU - Moretti, F.
AU - Soricelli, A.
AU - Spessotto, P.
AU - Iorio, E.
N1 - Export Date: 19 February 2021 CODEN: IBMAE Correspondence Address: Canese, R.; Istituto Superiore di SanitàItaly; email: rossella.canese@iss.it Chemicals/CAS: Biomarkers References: Saracci, R., Epidemiology in wonderland: Big data and precision medicine (2018) Eur J Epidemiol, 33, pp. 245-257; Khleif, S.N., Doroshow, J.H., Hait, W.N., AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development (2010) Clin Cancer Res, 16, pp. 3299-3318; Christofi, T., Baritaki, S., Falzone, L., Current perspectives in cancer immunotherapy (2019) Cancers (Basel), 11, p. 1472; Marshall, H.T., Djamgoz, M.B.A., Immuno-oncology: emerging targets and combination therapies (2019) Front Oncol, 8, p. 315; Olivier, M., Asmis, R., Hawkins, G.A., The need for multi-omics biomarker signatures in precision medicine (2019) Int J Mol Sci, p. 20; Zou, J., Wang, E., Cancer biomarker discovery for precision medicine: new progresses (2018) Curr Med Chem, , 2018/07/22. CMC-EPUB-91805; Li, L., Zhang, J., Jiang, X., Promising clinical application of ctDNA in evaluating immunotherapy efficacy (2018) Am J Cancer Res, 8, pp. 1947-1956; Snyder, A., Morrissey, M.P., Hellmann, M.D., Use of circulating tumor DNA for cancer immunotherapy (2019) Clin Cancer Res, , 2019/07/10. 1078-0432.CCR-18-2688; Seyhan, A.A., Carini, C., Are innovation and new technologies in precision medicine paving a new era in patients centric care? (2019) J Transl Med, 17, p. 114; Vandenbrouck, Y., Christiany, D., Combes, F., Bio-informatics tools and workflow to select blood biomarkers for early cancer diagnosis: an application to pancreatic cancer (2019) Proteomics, p. e1800489; Wei, H., Jiang, H., Song, B., Role of medical imaging for immune checkpoint blockade therapy: From response assessment to prognosis prediction (2019) Cancer Med, 8, pp. 5399-5413; Seymour, L., Bogaerts, J., Perrone, A., iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics (2017) Lancet Oncol, 18, pp. e143-e152; Marcu, L.G., Forster, J.C., Bezak, E., The potential role of radiomics and radiogenomics in patient stratification by tumor hypoxia status (2019) J Am Coll Radiol, 16, pp. 1329-1337; Forster, J.C., Marcu, L.G., Bezak, E., Approaches to combat hypoxia in cancer therapy and the potential for in silico models in their evaluation (2019) Phys Med, 64, pp. 145-156; Thews, O., Riemann, A., Tumor pH and metastasis: a malignant process beyond hypoxia (2019) Cancer Metastasis Rev, 38, pp. 113-129; Pillai, S.R., Damaghi, M., Marunaka, Y., Causes, consequences, and therapy of tumors acidosis (2019) Cancer Metastasis Rev, 38, pp. 205-222; Weaver, O., Leung, J.W.T., Biomarkers and imaging of breast cancer (2019) AJR Am J Roentgenol, 210, pp. 271-278; Lim, J.C.T., Yeong, J.P.S., Lim, C.J., An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use (2018) Pathology, 50, pp. 333-341
PY - 2019
Y1 - 2019
KW - biological marker
KW - circulating microRNA
KW - tumor marker
KW - Article
KW - cancer diagnosis
KW - cancer prognosis
KW - clinical practice
KW - computer assisted tomography
KW - genomics
KW - human
KW - hypoxia
KW - inflammation
KW - inflammatory disease
KW - malignant neoplasm
KW - metabolomics
KW - metastasis
KW - molecular imaging
KW - nuclear magnetic resonance imaging
KW - oncology
KW - personalized medicine
KW - positron emission tomography-computed tomography
KW - single photon emission computed tomography
KW - tumor growth
KW - tumor microenvironment
KW - blood
KW - metabolism
KW - procedures
KW - Biomarkers
KW - Humans
KW - Inflammation
KW - Medical Oncology
KW - Molecular Imaging
U2 - 10.1177/1724600819897926
DO - 10.1177/1724600819897926
M3 - Article
VL - 35
SP - 5
EP - 7
JO - Int. J. Biol. Markers
JF - Int. J. Biol. Markers
SN - 0393-6155
IS - 1_suppl
ER -